Sign Up Today and Learn More About Candid Health Stock
Invest in or calculate the value of your shares in Candid Health or other pre-IPO companies through EquityZen's platform.

Candid Health Stock (CANH)
Candid is a modern medical insurance billing platform
About Candid Health Stock
Founded
2019
Headquarters
San Francisco, CA, US
Industries
Software, Artificial Intelligence, Data and Analytics
Candid Health is a platform that uses AI for automated medical billing. They undergo regular HIPAA audits by industry-leading security experts to protect the client's patients’ security and privacy. And uses AI to learn insurance submission rules in real-time, so they never make the same mistake twice.
Candid Health Press Mentions
Stay in the know about the latest news on Candid Health
Candid Health Named to the 2026 New York Digital Health 100
prnewswire • Feb 04, 2026
Candid Health to open new office in Flatiron District
bizjournals • Jan 28, 2026
Turning Operational Efficiency Into Brand Equity
medcitynews • Dec 31, 2025
Candid Health Named a Fierce Healthcare Innovation Awards Winner in the Financial Solutions Category
prnewswire • Nov 19, 2025
Questex’s Fierce Healthcare Announces 2025 Innovation Awards Winners
globenewswire • Nov 19, 2025
Candid Health Management
Leadership team at Candid Health
COO
Doug Proctor
Co-founder and CEO
Nick Perry

Join now and verify your accreditation status to gain access to:
- Candid Health Current Valuation
- Candid Health Stock Price
- Candid Health Management
- Available deals in Candid Health and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Candid Health Cap Table and Funding History by Share Class and Liquidity Preferences
- Candid Health Revenue and Financials
- Candid Health Highlights
- Candid Health Business Model
- Candid Health Risk Factors
- Candid Health Research Report from SACRA Research
Trading Candid Health Stock
How to invest in Candid Health stock?
Accredited investors can buy pre-IPO stock in companies like Candid Health through EquityZen funds. These investments are made available by existing Candid Health shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Candid Health stock?
Shareholders can sell their Candid Health stock through EquityZen's private company marketplace. EquityZen's network includes over 450K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 53K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."




